Wuya College of Innovation;
Key Laboratory of Structure-Based Drug Design&Discovery;
Ministry of Education;
Shenyang Pharmaceutical University;
Shenyang 110016;
China;
The Institute of Rehabilitation Industry;
Fujian University of Traditional Chinese Medicine;
Fuzhou 350122;
China;
Institute of Structural Pharmacology&TCM Chemical Biology;
College of Pharmacy;
Fujian University of Traditional Chinese Medicine;
Fuzhou 350122;
China;
IDH1; Cancer; Regulatory mechanisms; IDH1 inhibitors; D-2HG; Metabolic reprogramming; Epigenetics; Immune microenvironment;